Projected Income Statement: Pandox AB

Forecast Balance Sheet: Pandox AB

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 31,030 35,464 34,857 37,413 51,860 48,067 48,190 48,321
Change - 14.29% -1.71% 7.33% 38.61% -7.31% 0.26% 0.27%
Announcement Date 2/10/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1SEK in Million
Estimates

Cash Flow Forecast: Pandox AB

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 531 898 2,375 1,024 1,087 1,251 1,193 1,217
Change - 69.11% 164.48% -56.88% 6.15% 15.09% -4.68% 2.02%
Free Cash Flow (FCF) 1 -1,091 740 712 802 2,014 12,155 1,826 1,696
Change - 167.83% -3.78% 12.64% 151.12% 503.53% -84.97% -7.12%
Announcement Date 2/10/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1SEK in Million
Estimates

Forecast Financial Ratios: Pandox AB

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 57.07% 58.44% 53.96% 55.51% 54.71% 61.45% 61.81% 61.61%
EBIT Margin (%) 47.97% 52.19% 53.44% 51.22% 53.37% 58.92% 59.12% 58.97%
EBT Margin (%) 27.07% 94.64% -7.26% 33.06% 51.49% 38.6% 41.72% 42.47%
Net margin (%) 18.64% 74.58% -8.54% 23.67% 42.03% 26.52% 32.1% 32.62%
FCF margin (%) -33.33% 13.09% 10.4% 11.24% 26.96% 145.16% 21.25% 19.29%
FCF / Net Income (%) -178.85% 17.55% -121.71% 47.48% 64.16% 547.4% 66.21% 59.12%

Profitability

        
ROA 0.93% 5.94% -0.79% 2.19% - - - -
ROE 2.49% 15.08% -1.94% 5.35% 9.33% 5.99% 5.71% 5.6%

Financial Health

        
Leverage (Debt/EBITDA) 16.61x 10.73x 9.43x 9.45x 12.69x 9.34x 9.07x 8.92x
Debt / Free cash flow -28.44x 47.92x 48.96x 46.65x 25.75x 3.95x 26.38x 28.48x

Capital Intensity

        
CAPEX / Current Assets (%) 16.22% 15.88% 34.68% 14.35% 14.55% 14.94% 13.88% 13.83%
CAPEX / EBITDA (%) 28.43% 27.18% 64.26% 25.85% 26.6% 24.31% 22.45% 22.45%
CAPEX / FCF (%) -48.67% 121.35% 333.57% 127.68% 53.97% 10.29% 65.29% 71.72%

Items per share

        
Cash flow per share 1 - - - - - - - -
Change - - - - - - - -
Dividend per Share 1 - 2.5 4 4.25 4.5 4.75 5.114 5.448
Change - - 60% 6.25% 5.88% 5.56% 7.65% 6.55%
Book Value Per Share 1 137.1 167.2 160.8 172.3 173.3 183.2 195.9 208.6
Change - 21.89% -3.77% 7.11% 0.6% 5.71% 6.91% 6.48%
EPS 1 3.32 22.94 -3.18 9.04 16.13 12.14 14.18 14.75
Change - 590.96% -113.86% 384.28% 78.43% -24.75% 16.8% 4.02%
Nbr of stocks (in thousands) 183,850 183,850 183,850 194,603 194,603 194,603 194,603 194,603
Announcement Date 2/10/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1SEK
Estimates
2026 *2027 *
P/E 14.2x 12.1x
PBR 0.94x 0.88x
EV / Sales 9.73x 9.5x
Yield 2.76% 2.98%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
171.80SEK
Average target price
213.60SEK
Spread / Average Target
+24.33%

Quarterly revenue - Rate of surprise